Niraparib in Combination With Osimertinib in EGFR-Mutated Advanced Lung Cancer
about
Niraparib in Combination With Osimertinib in EGFR-Mutated Advanced Lung Cancer
description
clinical trial
@en
klinisch onderzoek
@nl
name
Niraparib in Combination With Osimertinib in EGFR-Mutated Advanced Lung Cancer
@en
type
label
Niraparib in Combination With Osimertinib in EGFR-Mutated Advanced Lung Cancer
@en
prefLabel
Niraparib in Combination With Osimertinib in EGFR-Mutated Advanced Lung Cancer
@en
P1476
Phase 1 Study of Niraparib in ...... R-Mutated Advanced Lung Cancer
@en
P3098
NCT03891615
P4844
P580
2019-04-30T00:00:00Z
P582
2022-04-30T00:00:00Z